I would like to thank all AMBS shareholders for sticking with the Company during a very difficult 2015-2017 for all. We are hopeful to complete the fundamental turnaround in 2018 and put #MANF#ESS#ELTO on the path to regulatory approval so patients can benefit. $AMBS